Affluent Medical Stock Now Covered by Gilbert Dupont – Société Générale Group

Affluent Medical, a frontrunner French MedTech company, has officially announced that its stock will now be covered by Gilbert Dupont – Société Générale Group. This development was released in a press notice on April 4th, 2024. With a focus on international development and industrialization of pioneering medical prostheses, this signals a noteworthy progression for the company.

The coverage was initiated with a promising report titled "Un pour tous, tous pour un" which translates to "one for all and all for one," advocating a buy recommendation for the stock. The report, published on April 3rd, 2024, sets a target price of €3.30 for the stock, foreseeing an 89% potential increase from its closing price on April 2nd, 2024. This vote of confidence from Gilbert Dupont – Société Générale Group adds a significant accolade to Affluent Medical's stock, complementing previous assessments by Invest Securities, Kepler Cheuvreux, Portzamparc BNP Paribas Group, and TP ICAP Midcap.